Author:
Tseng Pei-Ying,Sung Fung-Chang,Muo Chih-Hsin,Lan Yu-Ching,Hser Yih-Ing,Chien Sarina Hui-Lin,Wang Jong-Yi
Abstract
Abstract
Background
A population-based follow-up study assessing the risk of developing hypertension and diabetes associated with alcohol use disorder (AUD) is crucial. We investigated this relationship by using insurance claims data from Taiwan.
Methods
From the claims data, an AUD cohort (N = 60,590) diagnosed between 2000 and 2006 and a non-AUD comparison cohort (N = 60,590) without the diagnosis of hypertension or diabetes at baseline were established and matched by propensity scores estimated by baseline demographic status and the Charlson comorbidity index (CCI). We assessed the incidence rates of hypertension and/or diabetes at the end of 2016 and used Cox’s method to estimate the related hazard ratios (HRs) and 95% confidence intervals (CIs).
Results
Relative to the comparison cohort, the AUD cohort had an approximately 1.70-fold higher incidence of hypertension (35.1 vs. 20.7 per 1,000 person-years), with an adjusted HR (aHR) of 1.72 (95% CI: 1.68–1.76), 2.16-fold higher incidence of diabetes (20.2 vs. 9.36 per 1,000 person-years), with an aHR of 2.18 (95% CI: 2.11–2.24), and 1.91-fold higher incidence of both diabetes and hypertension (10.3 vs. 5.38 per 1,000 person-years) with an aHR of 2.02 (95% CI: 1.94–2.10). The incidence rates of all outcomes were greater in men than in women, whereas the HRs were greater for AUD in women than for AUD in men relative to the respective comparison patients. The risk increased further for subjects with CCI ≥ 1, which was higher in the AUD cohort.
Conclusions
The increased risk of developing diabetes and hypertension in patients with AUD, especially the differences noted according to gender, indicates that clinicians should address potential comorbidities in these patients.
Funder
Taiwan Ministry of Health and Welfare Clinical Trial Center
China Medical University Hospital
Ministry of Science and Technology
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Pastor A, Conn J, MacIsaac RJ, Bonomo Y. Alcohol and illicit drug use in people with diabetes. Lancet Diabetes Endocrinol. 2020;8:239–48.
2. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
3. Liang Z, Qiu QY, Wu JH, Zhou JW, Xu T, Zhang MZ, et al. Alcohol drinking, dyslipidemia, and diabetes: a population-based prospective cohort study among inner mongolians in China. Biomed Environ Sci. 2016;29:555–62.
4. Menke A, Casagrande S, Cowie CC. Cardiometabolic health in asians with diabetes in the US. Diabetes Res Clin Pract. 2017;133:13–9.
5. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.